Transfer of Patent and Trade Mark Portfolio

In March 2023, the patents and trade marks relating to macular carotenoids held by the Howard Foundation Group, alongside associated intellectual property arising from research sponsored over the last 15 years, were assigned to Maravilla LLC, a US company formed by the two main business partners Industrial Organica (IOSA) and Macuhealth.

Jon Howard, director of Howard Foundation Holdings, reflected on the significance of the patents: “The first set of patents resulted from research into the prevention of Age-related Macular Degeneration. The latest patents cover how macular carotenoids help to improve visual performance and, when combined with fish oil, also slow the effects of Alzheimer’s Disease.

Julie Lambert, Chair of the Board of Trustees of the Howard Foundation commented: “In a lifetime of research, my father, the late Dr. Alan Howard, had the vision to create patents to protect the quality and use of the products that came from that research. Through the Howard Foundation, this culminated in a series of patents and trademarks developed for use in eye and brain health. We are pleased to pass these patents on to our long-term business partners.

The Foundation continues to support research and conferences in the field of macular carotenoids.

For further information see the Maravilla website.